Effects of a 12-wk whole-body vibration based intervention to improve type 2 diabetes.

Author: Del Pozo-Cruz B, Alfonso-Rosa RM, Del Pozo-Cruz J, Sañudo B, Rogers ME.
Affiliation: Department of Sport and Exercise Science, University of Auckland, Auckland, New Zealand. Electronic address: b.delpozocruz@auckland.ac.nz.
Conference/Journal: Maturitas.
Date published: 2013 Sep 18
Other: Pages: S0378-5122(13)00289-2. , Special Notes: doi: 10.1016/j.maturitas.2013.09.005 , Word Count: 223

To test the feasibility, safety and effectiveness of a 12-wk whole body vibration (WBV) intervention on glycemic control, lipid-related cardiovascular risk factors and functional capacity among type 2 diabetes mellitus (T2DM) patients in a primary care context.
Fifty non-insulin dependent T2DM patients were randomized 1:1 to an intervention group that, in addition to standard care, received a 12-wk WBV intervention, and a control group receiving only standard care (from February 2012 through May 2012). Outcomes, including glycated hemoglobin (HbA1c), fasting blood glucose, lipid-related cardiovascular risk factors (i.e., cholesterol, triglycerides, lipoproteins, LDL/HDL and atherogenic index) and functional capacity were measured at baseline and after the 12-wk intervention.
After intervention, there was a reduction in HbA1c and fasting blood glucose when compared to the control group, with a mean difference in change scores between groups of -0.55% (95% CI -0.15 to -0.76) and -33.95mm/dl (95% CI -51.38 to -3.47), respectively. Similarly, most lipid-related cardiovascular risk factors (i.e., cholesterol, triglycerides and atherogenic index) were also reduced (p<0.05).
A 12-wk WBV intervention in a primary care context is feasible, safe and effective in improving glycemic profile, lipid-related cardiovascular risk factors and functional capacity among T2DM patients.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.
Diabetic patients, Exercise therapy, Glycemic control, Prevention therapy, Vibration therapy

PMID: 24094494